24560 Federal Register / Vol. 63, No. 85 / Monday, May 4, 1998 / Notices

Enter several times and then select

menu choice 1: FDA BULLETIN BOARD

SERVICE. From there follow

instructions for logging in, and at the

BBS TOPICS PAGE, arrow down to the

FDA home page (do not select the first

CDRH entry). Then select Medical

Devices and Radiological Health. From

there select CENTER FOR DEVICES

AND RADIOLOGICAL HEALTH for

general information, or arrow down for

specific topics.

IV. Comments

Interested persons may, on or before

August 3, 1998, submit to the Dockets

Management Branch written comments

regarding this guidance document. Two

copies of any comments are to be

submitted, except that individuals may

submit one copy. Comments are to be

identified with the docket number

found in brackets in the heading of this

document. The guidance document and

received comments may be in the

Dockets Management Branch (address

above) between 9 a.m. and 4 p.m.,

Monday through Friday.

Dated: April 14, 1998.

D.B. Burlington,

Director, Center for Devices and Radiological

Health.

[FR Doc. 98–11683 Filed 5–1–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

John E. Fogarty International Center

for Advanced Study in the Health

Sciences; Notice of Meeting of the

Fogarty International Center Advisory

Board

Pursuant to Public Law 92–463, as

amended, notice is hereby given of the

thirty-eighth meeting of the Fogarty

International Center (FIC) Advisory

Board, May 19, 1998, in the Lawton

Chiles International House (Building 16)

at the National Institutes of Health. The

Research Awards Subcommittee will

meet on May 18 in the FIC Conference

Room, Building 31, Room B2C07, from

1:00 p.m. to approximately 4:00 p.m.,

and will be closed to the public.

The meeting of the Board will be open

to the public from 8:30 a.m. to

approximately 12:00 noon.

In addition to a report by the Director,

FIC, the agenda will include

presentations on FIC Evolution and

Long-Range Planning; the Status of FIC

International Training and Research

Programs; ICD-Wide Initiatives in

Support of International Relations; and

FIC International Policy Support to NIH

and other Government Agencies.

In accordance with the provisions of

sections 552b(c)(4) and 552b(c)(6), Title

5, United States Code and section 10(d)

of Public Law 92–463, as amended, the

entire meeting of the Research Awards

Subcommittee on May 18 will be closed

to the public from 1:00 p.m. to

approximately 4:00 p.m., and the Board

meeting on May 19 will be closed to the

public from 1:00 p.m. to adjournment

for the review of applications for awards

under the Senior International

Fellowship and International

Fellowship Programs; and the Fogarty

International Research Collaboration

Awards and HIV, AIDS and Related

Illnesses Collaboration Awards.

Paula Cohen, Committee Management

Officer, Fogarty International Center,

National Institutes of Health, Building

31, Room B2C08, 31 CENTER DR MSC

2220, Bethesda, Maryland 20892–2220,

telephone: 301–496–1491, will provide

a summary of the meeting and a roster

of the committee members upon

request.

Irene Edwards, Executive Secretary,

Fogarty International Center Advisory

Board, Building 31, Room B2C08,

telephone: 301–496–1491, will provide

substantive program information.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Cohen at least 2 weeks in

advance of the meeting.

(Catalog of Federal Domestic Assistance

Program No. 93.989, Senior International

Fellowship Awards Programs; and 93.934,

Fogarty International Research Collaboration

Award)

Dated: April 24, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–11676 Filed 5–1–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Meeting of the National Cancer

Advisory Board and Its Subcommittees

Pursuant to the Federal Advisory

Committee Act, as amended, notice is

hereby given of the meeting of the

National Cancer Advisory Board

(Board), National Cancer Institute (NCI),

and its Subcommittees on May 11–13,

1998. The meeting of the Board and its

Subcommittees will be open to the

public as indicated below. Attendance

by the public will be limited to space

available.

A portion of the Board meeting will

be closed to the public as indicated

below in accordance with the provisions

set forth in sections 552(c)(4) and

552(c)(6), Title 5 U.S.C. and section

10(d) of Public Law 92–463, for the

review, discussion and evaluation of

individual grant applications and for

discussion of issues pertaining to

programmatic areas and/or NCI

personnel. These applications and

discussions could reveal confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning the

individuals associated with the

applications or programs, the disclosure

of which would constitute a clearly

unwarranted invasion of personal

privacy.

The Committee Management Office,

National Cancer Institute, National

Institutes of Health, Executive Plaza

North, Room 609, 6130 Executive

Boulevard, MSC 7410, Bethesda,

Maryland 20892–7410, (310) 496–5708

will provide summaries of the meetings

and rosters of the Board members, upon

request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Mrs. Linda Quick-Cameron,

Committee Management Officer, at (301)

496–5708 in advance of the meetings.

Name of Committee(s): Subcommittee on

Activities and Agenda, Subcommittee on

Cancer Centers, Subcommittee on Clinical

Investigations, Subcommittee on Planning

and Budget.

Date: May 11, 1998.

Time: 7:00 p.m.—Adjournment.

Place: Hyatt Regency Bethesda, One

Bethesda Metro, Bethesda, Maryland 20814.

Agenda(s): See NCI Homepage/Advisory

Board and Groups,

http://deainfo.nci.nih.gov/ADVISORY/

boards.htm

Tentative agenda available 10 working

days prior to meetings;

Final agenda available 5 working days

prior to meetings.

Contact Person: Dr. Marvin R. Kalt,

Executive Secretary, National Cancer

Institute, NIH, Executive Plaza North, Room

600, 6130 Executive Blvd., MSC 7405,

Bethesda, MD 20892–7405, (301) 496–5147.

Name of Committee: National Cancer

Advisory Board.

Dates: May 12–13, 1998.

Place: Building 31C, Conference Room 10,

National Institutes of Health, 3100 Center

Drive, Bethesda, MD. 20892.

Open: May 12—9:00 a.m. to 4:00 p.m.; May

13—9:00 a.m. to 12:20 p.m.

Agenda: Program reports and

presentations; business of the Board. For a